In Law360, Margaux Hall Discusses Trump Executive Order on Medicare Drug Pricing

In The News
January 29, 2025

In a Law360 article, health care partner Margaux Hall, who leads the firm’s drug pricing and price reporting group, noted that President Trump’s recent executive orders—rescinding President Biden’s drug pricing CMMI directives—do not alter the Medicare negotiation program under the Inflation Reduction Act, as that negotiation program “has its own legal authority under federal law.”